Andres Cervantes
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Andres Cervantes
Jul 24, 2024, 14:09 |
Blog
Matteo Lambertini: Fantastic ESMO Course in Medical Oncology for Medical Students
Matteo Lambertini shared on X: "What a fantastic ESMO Course in Medical Oncology for Medical Students…really…
Jul 4, 2024, 11:21 |
Blog
Florian Lordick: New first-line treatment algorithm for advanced gastric cancer published in ESMO
Florian Lordick, Director of Education at ESMO, shared on LinkedIn: "New first-line treatment algorithm for…
Jun 29, 2024, 11:21 |
Societies
Highlights from ESMOGI24 by Angela Lamarca
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 26, 2024, 13:38 |
Societies
Angela Lamarca: Opening Press Conference at ESMOGI24
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post by…
May 23, 2024, 14:29 |
Societies
The names of the candidates running for the ESMO Presidency 2027-2028 have been announced
The names of the candidates running for the ESMO Presidency 2027-2028 have been announced. Find…
Apr 29, 2024, 15:33 |
Blog
Lucjan Wyrwicz: European perspective of OMEC-4 survey
Lucjan Wyrwicz, Medical Oncologist at Maria Curie National Cancer Research Institute in Warsaw, Poland, recently…
Mar 25, 2024, 15:15 |
Societies
25 Posts Not To Miss From ELCC 2024
The European Lung Cancer Congress (ELCC 2024) took place in Prague, Czech Republic, from 20th…
Feb 10, 2024, 23:10 |
Blog
The WHO-ESMO Collaboration Plan for 2024-2026 has identified three key areas of intervention
ESMO - European Society for Medical Oncology, made the following post on LinkedIn: "The WHO-ESMO…
Nov 12, 2023, 17:50 |
Insight
Andres Cervantes: Updated treatment recommendation for third-line treatment in advanced colorectal cancer from ESMO
Andres Cervantes, Professor Medical Oncologist at Hospital University of Valencia, posted on X/Twitter: "Updated treatment…
Nov 4, 2023, 17:29 |
Blog
David Sebag: Delighted our letter about the PROSPECT rectal cancer trial
Quoting David Sebag-Montefiore, Director at Leeds Cancer Research Centre, on X/Twitter: “Delighted our letter about…
Nov 1, 2023, 18:31 |
Drugs
David Sebag-Montefiore: We strongly caution against the use of FOLFOX alone applied to the whole PROSPECT trial population
David Sebag-Montefiore shared on LinkedIn: "Delighted to see our letter published in the New England Journal…
Oct 23, 2023, 13:21 |
Career
Florian Lordick: Honoured having received the FESMO award from ESMO President Andres Cervantes
Florian Lordick, Professor of Medicine and Director of the University Cancer Center Leipzig, shared on…
Oct 21, 2023, 19:09 |
Societies
Evandro de Azambuja: We are over 34,000 members at ESMO
Evandro de Azambuja, ESMO Director of Membership 2023-2024, shared on his Twitter: "As the ESMO…
Sep 12, 2023, 20:03 |
Blog
Jon Lim: Super excited to be in Naples this week to teach and hopefully inspire our next generation of 60+ medical students.
Quoting Jon Lim, Medical Oncologist & Postdoctoral Clinical Fellow at The Francis Crick Institute, on…
All:
14
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube